TGTX
TGTX
NASDAQ · Biotechnology

Tg Therapeutics Inc

$58.11
+0.95 (+1.66%)
As of Sep 22, 9:53 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 1 7%
Sell 1 7%
Price Target
Analyst Price Target +7.4% upside
Low Target $43.17
Average Target $62.39
High Target $72.87
Current Price $58.11
Current
$58.11
Target
$62.39
$43.17 $62.39 avg $72.87
Scenario Analysis
Bear Case
$43.17
-25.7%
Low target
Base Case
$62.39
+7.4%
Avg target
Bull Case
$72.87
+25.4%
High target
Risk/Reward
1.0x
Unfavorable
Price in Context
52-Week High
$59.30
-2.0% from high
52-Week Low
$26.76
+117.2% from low
50-Day SMA
$30.02
+93.6% vs SMA
200-Day SMA
$32.89
+76.7% vs SMA
RSI (14)
46.3
Neutral
Target vs 52W High
$62.39
+5.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%